Texas Liver Institute

What Texas Liver Institute does

Texas Liver Institute (TLI) is a Texas-incorporated non-profit organization founded in 2012 and headquartered in San Antonio, operating across five Texas locations (Downtown, Medical Center, and North San Antonio, plus Austin, Corpus Christi, and Laredo). The institute is structured around two wholly-owned operating entities: Texas Liver Consultants (TLC), a freestanding clinical practice providing hepatology consultations, Fibroscan/elastography imaging, liver biopsy, and pre/post-transplant care for patients with viral hepatitis, fatty liver disease (including MASLD/NASH), autoimmune liver disease, liver cancer, and cirrhosis; and American Research Corporation (ARC), a freestanding clinical research facility operating a 24-bed inpatient Phase 1 unit and a comprehensive outpatient research unit, conducting all phases of clinical trials for pharmaceutical sponsors. TLI also runs an accredited Transplant Hepatology Fellowship Program in partnership with UT Health San Antonio and coordinates transplant care through a 40+ year partnership with the University Health System, which has performed over 1,400 liver transplants since 1992 and is rated "Best in Texas" for patient survival by the Scientific Registry of Transplant Recipients.

The institute's GTM is physician-referral-driven: patients are referred by primary care physicians and gastroenterologists through online forms, email, fax, and direct phone, and the institute accepts most major insurance plans with alternative payment options for uninsured patients. Research trials are a separate channel handled through ARC. The institute is co-led by Dr. Eric Lawitz (VP, Scientific and Research Development) and Dr. Fred Poordad (VP, Academic and Clinical Affairs), each with over 300 publications in top-tier journals including the New England Journal of Medicine and The Lancet. Revenue mechanics are split across insurance reimbursements for clinical services, pharmaceutical company research grants for clinical trials, and academic funding for education and fellowship programs; the institute has delivered $150,000,000 in free care to South Texas patients over two years through its drug development program.

TLI's service mix is anchored by three strategic partnerships: the Texas Liver Tumor Center (a tripartite partnership with University Health System and UT Health San Antonio for multidisciplinary liver tumor care), the long-standing University Health transplant partnership, and the UT Health San Antonio academic affiliation that supplies the trainee pipeline. The Metabolic Liver Disease Program (Austin), the Hepatobiliary Cancer program, and a bilingual English/Spanish patient education platform round out the offering. Marketing is modest — a website, Facebook/Twitter/LinkedIn presence, quarterly newsletters, and conference sponsorships (GALA, Chronic Liver Disease Foundation, AASLD, EASL) — consistent with a non-profit operating on referral relationships rather than consumer demand generation.

Name

Texas Liver Institute

Legal name

Texas Liver Institute

Website

https://txliver.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Texas Liver Institute is a non-profit hepatology organization in San Antonio, Texas, operating five clinics and a large freestanding clinical research facility that delivers specialized liver disease care, clinical trials, and transplant coordination to patients across Texas and internationally.

Ownership category

akta.pro rank

Product category

Hepatology and Liver Disease Specialty Care

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Ambulatory Health Care Services (621)

SIC

Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Hepatology & Liver Disease (HLAKAEAB)

akta.pro secondary industries

Transplant Hepatology (HLAKAEAK), Liver & GI Clinical Research (Trials Centers) (HLAKAEAL)

Keywords

• Hepatology clinical care
• Liver disease treatment
• Clinical research services
• Liver transplant care
• Fibroscan elastography imaging

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Patient Care (Texas Liver Consultants - TLC): Direct clinical healthcare services for patients with liver disease including consultations, diagnostics, treatments, and procedures. Revenue generated through insurance reimbursements and patient payments.
2. Clinical Research (American Research Corporation - ARC): Clinical trial conduct for pharmaceutical companies and research sponsors. Funding from pharmaceutical companies for research grants, drug development programs, and clinical studies. The institute has delivered $150,000,000 in free care to patients over two years through drug development programs.
3. Academic and Educational Services: Fellowship programs, medical education, and training for healthcare professionals. Hosted conferences and symposia including GALA, Chronic Liver Disease Foundation, and South Texas Liver Club.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Texas Liver Institute (TLI) is a non-for-profit organization that delivers comprehensive hepatology clinical care through its subsidiary Texas Liver Consultants (TLC) and conducts all phases of clinical research through its subsidiary American Research Corporation (ARC). The institute treats viral hepatitis, fatty liver disease, autoimmune liver disease, liver cancer, cirrhosis, and provides pre- and post-liver transplant care using diagnostics such as Fibroscan/elastography, liver biopsy, and comprehensive laboratory and imaging services. Patients are accepted primarily via physician referrals across five Texas locations, with additional revenue from pharmaceutical-sponsored clinical trials.

Product overview

Texas Liver Institute (TLI) is a non-for-profit organization comprising three interconnected entities: Texas Liver Consultants (TLC) for clinical patient care, American Research Corporation (ARC) for clinical research trials, and the Transplant Hepatology Fellowship Program for medical education. The institute offers a comprehensive suite of liver disease services including viral hepatitis treatment, fatty liver disease management, autoimmune liver disease care, liver cancer treatment, cirrhosis management, and pre/post-transplant care. Key specialized offerings include the Texas Liver Tumor Center (a partnership with University Health System and UT Health San Antonio) for multidisciplinary tumor treatment, Fibroscan/Elastography for non-invasive liver assessment, and the Metabolic Liver Disease Program. TLI serves patients from across the United States and internationally, with faculty who are hepatologists and professors of medicine at UT Health Science Center San Antonio.

Differentiator

Problem solved

Functional benefit

Products and services

• Texas Liver Consultants (TLC) - Clinical Services

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• University Health SystemcoreStrategic or Co-development PartnerOver 40-year partnership providing lifesaving solid organ transplants. University Health Transplant Institute (UHTI) is Best in Texas for Patient Survival for Liver Transplant according to Scientific Registry of Transplant Recipients. TLI faculty serve as Chief of Hepatology and Medical Director of Liver Transplant at University Health. Partnership includes liver, kidney, and lung transplant services. The only program in South Texas to offer Living Donor Liver Transplantation.
• UT Health San Antonio (University of Texas Health Science Center at San Antonio)coreStrategic or Co-development PartnerTLI physicians serve as professors of medicine and teach medical students, residents, and fellows at UT Health San Antonio. TLI is the academic clinical arm for hepatology. The partnership includes transplant hepatology fellowship program, liver transplant services, and collaborative research. Created accredited transplant hepatology fellowship program.
• Texas Liver Tumor CentercoreStrategic or Co-development PartnerPartnership between University Health System, UT Health San Antonio, and Texas Liver Institute creating a unique advanced healthcare system to treat liver tumors. Provides comprehensive multidisciplinary care with liver and cancer experts, social workers, dietitians, and health professionals under one roof in San Antonio. Enables streamlined consultation and treatment planning in a single visit.
• GI and Liver Association of the Americas (GALA)minorStrategic or Co-development PartnerGALA provides up-to-date education to physicians and healthcare professionals caring for patients with chronic liver and gastrointestinal disorders. TLI sponsors and participates in GALA conferences and educational activities.
• World Hepatitis AllianceminorStrategic or Co-development PartnerGlobal organization transforming the viral hepatitis agenda with goal to eliminate viral hepatitis as a public health threat by 2030. Focus on finding the 'Missing Millions' undiagnosed people living with viral hepatitis.
• Chronic Liver Disease FoundationminorStrategic or Co-development PartnerTLI sponsors and supports educational activities and conferences organized by the Chronic Liver Disease Foundation focused on advancing education about liver disease.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Alamo Clinical Research Associates: San Antonio-based clinical research site founded by Dr. Eric Lawitz prior to founding TLI. Operates in the same metro and therapeutic area (Hepatology trials) under common founder lineage.
• Cedars-Sinai Liver Disease & Transplant Center: Academic hepatology and liver transplant program where TLI co-founder Dr. Fred Poordad served as Chief of Hepatology for 11 years. Directly comparable academic hepatology model combining clinical care with translational research publications.
• Indiana University Health Hepatology: Academic hepatology group known for viral hepatitis and NASH trials; comparable to TLI in combining hepatology clinical care with a dedicated industry-sponsored clinical research footprint.
• Baylor University Medical Center Liver Transplant Program: Dallas-based liver transplant and hepatology program where TLI's Dr. Landaverde completed her transplant hepatology fellowship. Comparable academic-transplant hepatology model in Texas with strong industry-sponsored trial activity.

Broad incumbents

• Mount Sinai Recanati/Miller Transplantation Institute: Academic hepatology and liver transplant program where TLI's Dr. Tsai completed her transplant hepatology fellowship. Overlap in transplant hepatology training pipeline and NASH/MASLD research interests.
• Cleveland Clinic Hepatology: Multi-organ transplant and hepatology program with research arm. Serves as an academic quaternary referral center akin to TLI but at significantly greater scale and geographic reach.
• Mayo Clinic Hepatology: National hepatology referral center with clinical practice, transplant program, and Phase 1-3 trials capability. Larger, multi-specialty system that overlaps with TLI on complex liver care and clinical research.

Regional players

• Methodist Transplant Institute: Texas-based transplant program serving the Dallas-Fort Worth region. Competes with TLI-affiliated University Health Transplant Institute for state-level liver transplant referrals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TXLIVER
• Facebookfacebook.com/TheTexasLiverInstitute
• LinkedInlinkedin.com/company/the-texas-liver-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Texas Liver Institute